Stockreport

Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Denmark-based Novo Nordisk OCSE:NOVO B) NVO) is a global developer of drugs to treat chronic diseases, including diabetes, obesity and hemophilia. The company has sales [Read more]